Mitsubishi UFJ Asset Management’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14,693
| Closed | -$156K | – | 1616 |
|
|
2025
Q1 | $156K | Buy |
14,693
+1,232
| +9% | +$13K | ﹤0.01% | 984 |
|
|
2024
Q4 | $241K | Buy |
13,461
+4,647
| +53% | +$83.4K | ﹤0.01% | 964 |
|
|
2024
Q3 | $205K | Sell |
8,814
-832
| -9% | -$19.3K | ﹤0.01% | 961 |
|
|
2024
Q2 | $235K | Buy |
9,646
+7
| +0.1% | +$170 | ﹤0.01% | 947 |
|
|
2024
Q1 | $326K | Sell |
9,639
-441
| -4% | -$14.9K | ﹤0.01% | 916 |
|
|
2023
Q4 | $316K | Sell |
10,080
-773
| -7% | -$24.2K | ﹤0.01% | 968 |
|
|
2023
Q3 | $277K | Buy |
10,853
+606
| +6% | +$15.5K | ﹤0.01% | 991 |
|
|
2023
Q2 | $294K | Sell |
10,247
-6,581
| -39% | -$189K | ﹤0.01% | 988 |
|
|
2023
Q1 | $403K | Buy |
16,828
+1,038
| +7% | +$24.9K | ﹤0.01% | 945 |
|
|
2022
Q4 | $264K | Buy |
15,790
+1,875
| +13% | +$31.3K | ﹤0.01% | 993 |
|
|
2022
Q3 | $206K | Hold |
13,915
| – | – | ﹤0.01% | 1018 |
|
|
2022
Q2 | $219K | Buy |
13,915
+5,617
| +68% | +$88.4K | ﹤0.01% | 1033 |
|
|
2022
Q1 | $224K | Buy |
8,298
+687
| +9% | +$18.5K | ﹤0.01% | 1038 |
|
|
2021
Q4 | $301K | Sell |
7,611
-2,790
| -27% | -$110K | ﹤0.01% | 1008 |
|
|
2021
Q3 | $497K | Buy |
10,401
+270
| +3% | +$12.9K | ﹤0.01% | 944 |
|
|
2021
Q2 | $343K | Buy |
+10,131
| New | +$343K | ﹤0.01% | 1016 |
|